Picture EBD Group Asia Bio Partnering Forum 2024 Singapore 650x100px
Organisation › Details

Disco Pharmaceuticals (Group)

DISCO Pharma, operating out of Cologne, Germany and Schlieren, Switzerland, employs a disruptive scalable technology to map the surfaceome of cancer cells and develop first-in-class cancer drugs. With the advent of new cell-surface, target-directed therapeutic modalities (including ADCs and bi-specific antibodies), it is critical to ramp up the discovery of meaningful targets. DISCO does so by comprehensively identifying druggable targets, as well as protein communities (i.e., different proteins that form nanoscale organizations on a cell), across the entire cancer cell surface at scale, thus uncovering crucial new information that neither genome nor transcriptome sequencing can provide. By knowing which proteins are truly present on the cell surface, and how they are associated within protein communities, DISCO can design highly specific binders, boosting expected efficacy and reducing side effects. DISCO has a highly experienced team with a strong track record in cancer drug discovery and entrepreneurial value creation, as well as a deep understanding of surface proteomics born out of ETH in Zurich and developed further within the Company. DISCO is backed by world leading life sciences investors including Sofinnova Partners, Panakes Partners, M Ventures and AbbVie Ventures. *


Period Start 2022-03-30 established (s-off)
  Predecessor ETH Zürich (ETHZ)
Product Industry  cancer drug
Region Region Köln (Cologne)
  Country Germany
  Street 60-62 Gottfried-Hagen-Str.
  City 51105 Köln
  Tel +49-221-56086-197
    Address record changed: 2024-01-17
Basic data Employees n. a.
    * Document for »About Section«: Disco Pharmaceuticals GmbH. (1/16/24). "Press Release: Disco Pharmaceuticals Launches as the Surfaceome Company with EUR 20 Million in Seed Financing". Cologne & Zurich.
Record changed: 2024-01-17


Picture Bionter Seeing Things witzh EVE the Particle Counter 650x200px

More documents for Disco Pharmaceuticals (Group)

To subscribe to our free, monthly mass spectrometry newsletter, please send an e-mail to and simply fill the subject line with the word »MSC Newsletter«

Find more infos about advertising at [iito] web portals in our media flyer [iito] in a Nutshell [PDF file]

Please visit also our web portals for the Eurpean life sciences and the life sciences in German-speaking Europe (DE, AT & CH) at and


Picture Kenes Exhibitions Biomed Israel 2024 Tel Aviv 650x300px

» top